HOME >> BIOLOGY >> NEWS
Genome of Clostridium botulinum reveals the background to world's deadliest toxin

The genome of the organism that produces the worlds most lethal toxin is revealed today. This toxin is the one real weapon in the genome of Clostridium botulinum and less than 2 kg the weight of two bags of sugar is enough to kill every person on the planet. Very small amounts of the same toxin are used in medical treatments, one of which is known as Botox.

The genome sequence shows that C. botulinum doesnt have subtle tools to evade our human defences or tricky methods of acquiring resistance to antibiotics. It lives either as a dormant spore or as a scavenger of decaying animal materials in the soil, and doesnt interact with human or other large animal hosts for prolonged periods of time.

Occasionally it gets into a living animal, via contaminated food or open wounds, leading to infant botulism or wound botulism, both of which are serious human infections. The host can be quickly overpowered and, in some cases, killed by the toxin, and C. botulinum has a new food source.

"Although in the same group as Clostridium difficile the Cdiff superbug C. botulinum has a genome that is remarkable because it is so stable," commented Dr Mohammed Sebaihia, lead author on the paper from the Wellcome Trust Sanger Institute. "Unlike Cdiff, in which more than 10 per cent of genes have been acquired from other bacteria, there is almost no footprint of these in C. botulinum."

There are several types of C. botulinum: although described as variants of a single species, they are really very different organisms linked simply because they have the deadly toxin. For each type, there is also a near-identical but harmless relative that lacks the toxin. C. sporogenes is the non-malignant, near twin of the organism sequenced.

Professor Mike Peck, from the Institute of Food Research, commented that "It is astonishing that 43 per cent of the predicted genes in the C. botulinum genome are absent from the other five sequenced clostridia, an
'"/>

Contact: Don Powell
press.officer@sanger.ac.uk
University of Nottingham
25-May-2007


Page: 1 2 3

Related biology news :

1. The Cancer Genome Atlas awards funds for technology development
2. DOE Joint Genome Institute secures long-term lease on production genomics facility
3. DOE JGI upgrades its Microbial Genome Analysis System
4. Genome Canada, Gnome Qubec and Universit de Montral launch P3G Consortium and CARTaGENE Project
5. Genome of yellow fever/dengue fever mosquito sequenced
6. Genome-wide search unearths surprising clues for diabetes and triglycerides
7. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
8. No pain, DOE Joint Genome Institute gains coveted ergonomics prize with Shake N Plate
9. DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
10. Genome sequencing reveals key to viable ethanol production
11. Genome scan for familial autism finds two new genetic links

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... CellMax ... cancer cells in blood, will present new findings at the ASCO Gastrointestinal Cancer ... colorectal cancer. The results from this study show CellMax Life’s blood test, based ...
(Date:1/10/2019)... (PRWEB) , ... January 09, 2019 , ... Dr. Beanlands ... Heart Institute in Ottawa, Ontario, Canada. He is also Director of its National ... of Medicine, in the Department of Radiology, and in the Department of Cellular and ...
(Date:1/10/2019)... ... 2019 , ... A major goal for pharmaceutical companies has ... significantly more expensive in vivo studies in order to reduce costs and improve ... researchers have begun to adopt 3D cell culture models which have been shown ...
Breaking Biology News(10 mins):
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection ... changes in regulations in the European Union (EU) on the horizon, Jim Kasic, president ... , “The transition to the EU Medical Device Regulation (MDR), digital health, and big ...
(Date:12/18/2018)... ... December 18, 2018 , ... Patients with early stages of breast cancer who ... post-treatment versus whole breast irradiation, a new study suggests. , Patients with early stage ... irradiation after removal of the cancerous tumor because there is a 30 to 40 ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
(Date:12/5/2018)... (PRWEB) , ... December 04, ... ... an established North American full-service contract research organization (CRO), announced the acquisition ... transaction significantly strengthens ARG’s reach and experience in the management of clinical ...
Breaking Biology Technology:
Cached News: